Pathogenic germline <i>BRCA2</i> variants may be associated with an increased risk of hypopharyngeal squamous cell carcinoma that is more responsive to chemoradiation and chemotherapeutics targeting defective double-strand DNA repair. The gene discussed is BRCA2; the disease is hypopharynx squamous cell carcinoma.